Free Article with CME: Delayed IGF-1 Cure of Acromegaly

Background: Successful treatment of acromegaly is known to normalize serum insulin-like growth factor 1 (IGF-1) levels within days after surgery. However, our clinical observations indicate that many cases of acromegaly show delayed normalization of serum IGF-1 levels after complete tumor resection.

Objective: To study long-term changes of the serum IGF-1 levels in acromegalic patients for whom surgical treatment was thought to be successful.

Methods: A retrospective observational study was performed with 46 acromegalic patients with no residual tumor on sellar magnetic resonance imaging, and a nadir growth hormone of less than 0.4 μg/L on a postoperative oral glucose tolerance test.

Results: In all patients, serum IGF-1 levels returned to the normal reference values for age and sex during the observational period (12-132 months). The mean duration from the time of surgery until IGF-1 normalization was 10 months (range, 3 days-57 months). Twenty-seven patients (59%) reached normal IGF-1 ranges within 3 months of surgery, whereas 19 patients (41%) experienced delayed (>3 months) IGF-1 normalization. Eleven patients (24%) recovered normal IGF-1 levels 12 to 57 months after surgery. The possibility of delayed IGF-1 cure was increased 8.8-fold with an immediate postoperative IGF-1 level increase of 100 μg/L.

Conclusion: Satisfactory remission of acromegaly by IGF-1 criteria was delayed in a large proportion of acromegalic patients, especially those with high postoperative IGF-1 levels. Hence, additional treatment can be delayed in clinically stable acromegalic patients who show no evidence of residual tumors on postoperative magnetic resonance imaging and a normal growth hormone suppressive response to a glucose load.

From: Long-term Changes in Serum IGF-1 Levels After Successful Surgical Treatment of Growth Hormone-Secreting Pituitary Adenoma by Shin et al.

Free full text access.

SANS Neurosurgery members can earn CME credits from this article.

Combining the power of neurosurgery’s most popular online learning resource with its most influential peer-reviewed journal, SANS Neurosurgery offers subscribers the resources to stay ahead in the rapidly moving field. Test your knowledge and neurosurgical decision-making skills with questions pulled from each issue of Neurosurgery. This SANS product provides users with the latest pearls and constantly evolving information from the latest scientific neurosurgery articles.

One response to “Free Article with CME: Delayed IGF-1 Cure of Acromegaly

Comments are closed.